Australia 3D Printing Medical Devices Market Report 2022 to 2030

Australia 3D Printing Medical Devices Market Analysis

$ 3999

Australia's 3D printing medical devices market size was valued at $36 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $132 Mn in 2030. The market is segmented by component, application, technology, and end user. The Australia 3D Printing Medical Devices market will grow as 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. The key market players are Some of the key players in the market include Anatomics, Osteopore, MELD Manufacturing Corporation, 3D Medical Limited, Stratasys, Materialise, Stryker, and others.

ID: IN10AUMD002 CATEGORY: Medical Devices GEOGRAPHY: Australia AUTHOR: Chandani Patel

Buy Now

Australia 3D Printing Medical Devices Market Executive Summary

The Australia 3D Printing Medical Devices market size was valued at $36 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $132 Mn in 2030. In 2021, Australia's gross domestic product (GDP) was approximately $1.5 trillion. The country has a mixed-market economy, with a focus on services and resources. Australia has a publicly funded healthcare system, known as Medicare, which provides access to essential medical services, such as doctor visits, hospital care, and prescription drugs, to all citizens and permanent residents. In addition to the publicly funded system, Australia also has a private healthcare sector that provides more comprehensive and specialized medical care to those who can afford it. According to data from the World Bank, Australia's total healthcare expenditure was approximately 9.4% of its GDP in 2019. This represents a significant investment in healthcare and is comparable to the healthcare spending of other high-income countries.

3D printing technology is also being used in the medical device industry in Australia, and it is having a significant impact on the overall 3D printing market in the country. 3D printing is being used to produce a range of medical devices, including implants, prosthetics, dental devices, and surgical instruments.

One of the major benefits of 3D printing in the medical device industry is that it allows for the production of custom-made devices that are specifically tailored to the needs of individual patients. This can lead to better patient outcomes and improved quality of life. Additionally, 3D printing technology enables faster and more cost-effective production of medical devices compared to traditional manufacturing methods. The use of 3D printing technology in the medical device industry is driving growth in the overall 3D printing market in Australia. According to a report by Market Research Future, the Australian 3D printing market is expected to grow at a CAGR of 22.5% from 2020 to 2027, driven by the increasing adoption of 3D printing technology in various industries, including the medical device industry.

The growth of the 3D printing medical device market in Australia is being driven by several factors, including the increasing demand for custom-made medical devices, the growing prevalence of chronic diseases and the need for personalized medical solutions, and the increasing adoption of advanced manufacturing technologies by healthcare providers. With the increasing demand for personalized medical devices and the rising adoption of advanced manufacturing technologies, we can expect to see continued growth in the 3D printing medical device market in Australia in the coming years.

Australia 3D Printing Medical Devices Market

Market Dynamics

Market Growth Drivers

Increasing demand for personalized medical solutions: 3D printing technology allows for the production of customized medical devices that are tailored to the specific needs of individual patients. This is particularly important for prosthetics, implants, and other medical devices where a perfect fit is essential.
Growing prevalence of chronic diseases: The prevalence of chronic diseases, such as diabetes and cardiovascular disease, is increasing in Australia. 3D printing technology can be used to produce medical devices that address the specific needs of patients with these conditions, such as customized orthopedic implants or prosthetics.
Adoption of advanced manufacturing technologies: Australia is a leader in advanced manufacturing technologies, and the adoption of 3D printing technology is expected to continue to grow in the coming years. This will drive innovation in the medical device industry and lead to the development of new and more advanced medical devices.

Market Restraints

Regulatory challenges: The medical device industry in Australia is highly regulated, and there are strict requirements for the approval and commercialization of medical devices. These regulations can create barriers to entry for smaller companies and startups in the 3D printing medical device market.
Cost: 3D printing technology can be expensive, and the cost of producing 3D-printed medical devices may be higher than that of traditional manufacturing methods. This could limit the adoption of 3D printing technology in the medical device industry, particularly for smaller companies with limited resources.
Lack of standardization: There is currently a lack of standardization in the 3D printing medical device industry, which could impact the safety and reliability of 3D-printed medical devices. This could create challenges for regulatory approval and adoption by healthcare providers.

Competitive Landscape

Key Players

Anatomics: Anatomics is an Australian-based company that specializes in the design and manufacture of 3D-printed medical devices, including custom implants and prosthetics
Osteopore: Osteopore is an Australian-based company that produces 3D-printed implants for the cranial and maxillofacial regions
MELD Manufacturing Corporation: MELD Manufacturing Corporation is an Australian-based company that specializes in the production of 3D-printed orthopedic implants
3D Medical Limited: 3D Medical Limited is an Australian-based company that provides 3D printing services for the healthcare industry, including the production of custom implants and surgical tools
Stratasys: Stratasys is a US-based company that produces 3D printers and provides 3D printing services for a range of industries, including healthcare
Materialise: Materialise is a Belgian-based company that provides 3D printing services and software solutions for the healthcare industry
Stryker: Stryker is a US-based company that produces a range of medical devices, including 3D-printed implants and surgical instruments

Recent Developments

In 2021, Anatomics announced a new partnership with MTPConnect, an Australian medical technology, and pharmaceutical industry growth center. The partnership aims to accelerate the development and commercialization of innovative medical technologies, including 3D-printed medical devices
Osteopore announced that it had received regulatory approval in the US for its 3D-printed cranial implant in 2021. The implant is designed to help treat patients with skull defects caused by trauma or surgery
3D Medical Limited announced a new partnership with the University of Sydney to develop 3D-printed implants for the treatment of spinal injuries in 2021. The partnership aims to use 3D printing technology to produce custom implants that can be tailored to individual patients

Healthcare Policies and Regulatory Landscape

In Australia, the regulation of medical devices, including 3D-printed medical devices, is the responsibility of the Therapeutic Goods Administration (TGA). The TGA is an Australian government agency that regulates therapeutic goods, including medical devices, to ensure their safety, quality, and effectiveness. The TGA classifies medical devices into four classes based on their level of risk to patients. Class I devices, such as dental implants, are considered low risk, while Class IV devices, such as implantable cardiac pacemakers, are considered high risk.

Manufacturers of medical devices, including 3D-printed medical devices, must obtain approval from the TGA before their products can be sold in Australia. The approval process involves submitting an application to the TGA, which includes detailed information on the device's design, materials, and manufacturing processes. The TGA then conducts an assessment of the device's safety, quality, and effectiveness before granting approval.

In addition to regulatory approval, manufacturers of medical devices must also comply with Australian standards and guidelines for the design, testing, and manufacturing of medical devices. These standards are designed to ensure that medical devices are safe and effective and include guidelines for the use of 3D printing technology in the production of medical devices. The regulatory framework for 3D printing medical devices in Australia is robust and designed to ensure patient safety. Manufacturers must comply with strict requirements for the design, testing, and approval of their products before they can be sold in Australia.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Australia 3D Printing Medical Devices Market Segmentation

By Component

The Australia market is divided into three categories based on the component: equipment, materials, and software & services. End customers frequently employ software and services for designing and process control of 3D printed medical devices, particularly for bespoke items. The cost-effectiveness, utility, uniformity, and precision given by services for medical device 3D printing, together with a rise in demand for personalised 3D printed medical equipment among hospitals and surgical centres, are driving the market demand for software & surgical guides.

Equipment
- 3D Printers
- 3D Bioprinters
Materials
Plastics
- Thermoplastics
- Photopolymers
Metals and Metal Alloys
Biomaterials
Ceramics
Paper
Wax
Other Materials
Services & Software

By Application

The Australia market is divided into surgical guides, surgical tools, tissue-engineered goods, hearing aids, wearable medical devices/implantable medical devices, standard prostheses and implants, custom prosthetics and implants, and other medical devices based on the application. Due to the widespread adoption of 3D printing technology in the production of prosthetics and implants, the increased availability of high-quality biomaterials and ceramics for 3D printing, and ongoing industry investment in the development of novel 3D printers, the custom prosthetics and implants segment is expected to hold a larger share of the market in 2022.

Surgical Guides
- Dental Guides
- Craniomaxillofacial Guides
- Orthopedic Guides
- Spinal Guides
Surgical Instruments
Surgical Fasteners
Scalpels
Retractors
Standard Prosthetics & Implants
Orthopedic Implants
Dental Prosthetics & Implants
Craniomaxillofacial Implants
Bone & Cartilage Scaffolds
Ligament & Tendon Scaffolds
Custom Prosthetics & Implants
Tissue-engineered Products
Hearing Aids
Wearable Medical Devices
Other Applications

By Technology

According to technology, the global market has been divided into three categories: three-dimensional printing (3DP) or adhesion bonding; electron beam melting (EBM); laser beam melting (LBM); photopolymerization; droplet deposition or extrusion-based technologies; and other technologies. The laser beam melting (LBM) segment is anticipated to hold the greatest market share in 2022, in large part due to the growing use of this technology in the dental sector and for the production of implants for minimally invasive surgery.

Laser Beam Melting
- Direct Metal Laser Sintering
- Selective Laser Sintering
- Selective Laser Melting
- LaserCUSING
Photopolymerization
Digital Light Processing
Stereolithography
Two-photon Polymerization
PolyJet 3D Printing
Fused Deposition Modeling
Multiphase Jet Solidification
Low-temperature Deposition Manufacturing
Microextrusion Bioprinting
Droplet Deposition/Extrusion-based Technologies
Electron Beam Melting
Three-dimensional Printing/Adhesion Bonding/Binder Jetting
Other Technologies

By End User

The Australia market has been divided into hospitals and surgical facilities, dental and orthopaedic clinics, academic institutions and research labs, pharma-biotech and medical device firms, and clinical research organisations based on end users. In 2022, hospitals and surgical centres are anticipated to hold the greatest market share. The high proportion of this market may be due to the ongoing expansion of internal 3D printing capabilities, the expansion of existing 3D printing laboratories, the rising affordability of 3D printing services, and the quick uptake of cutting-edge technology by hospitals in developed markets.

Hospitals & Surgical Centers
Dental & Orthopedic Clinics
Academic Institutions & Research Laboratories
Pharma-Biotech & Medical Device Companies
Clinical Research Organizations

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.